Preclinical News and Research

RSS
CTRC commences patient enrolment in Phase 2 clinical trial of REOLYSIN for metastatic melanoma

CTRC commences patient enrolment in Phase 2 clinical trial of REOLYSIN for metastatic melanoma

Pre-clinical data demonstrates advantages of Combo Stent

Pre-clinical data demonstrates advantages of Combo Stent

New version of Adis R&D Insight global pipeline database launched

New version of Adis R&D Insight global pipeline database launched

Lux Biosciences announces results of its LX214 human safety study for dry eye syndrome

Lux Biosciences announces results of its LX214 human safety study for dry eye syndrome

VisEn launches new imaging agent for monitoring key hypertension and renal disease biomarker

VisEn launches new imaging agent for monitoring key hypertension and renal disease biomarker

Titanium dioxide nanoparticles catalyze brain tumor death

Titanium dioxide nanoparticles catalyze brain tumor death

Magnetic nanoworms and nanocrystals deliver siRNA to tumors

Magnetic nanoworms and nanocrystals deliver siRNA to tumors

The ThermoDox and MR-HIFU program shows great promise for treating life-threatening cancers

The ThermoDox and MR-HIFU program shows great promise for treating life-threatening cancers

Aspect and Bruker BioSpin collaborate to develop a new high performance desktop preclinical MRI system

Aspect and Bruker BioSpin collaborate to develop a new high performance desktop preclinical MRI system

Philips and Bruker sign MOU to develop new imaging technology

Philips and Bruker sign MOU to develop new imaging technology

ART's new generation Optix MX3 optical molecular imaging system unveiled

ART's new generation Optix MX3 optical molecular imaging system unveiled

FDA accepts Sangamo's IND for repeat-dosing in Phase 1 clinical trial of SB-728-T ZFN-based therapeutic

FDA accepts Sangamo's IND for repeat-dosing in Phase 1 clinical trial of SB-728-T ZFN-based therapeutic

New drug test promises to yield quick and effective response for cancer therapy

New drug test promises to yield quick and effective response for cancer therapy

SEA technology to increase potency of monoclonal antibodies

SEA technology to increase potency of monoclonal antibodies

Preclinical data on Protalix Biotherapeutics' antiTNF released

Preclinical data on Protalix Biotherapeutics' antiTNF released

Biotime's new subsidiary to focus on clinical development and marketing therapeutic stem cell products in China

Biotime's new subsidiary to focus on clinical development and marketing therapeutic stem cell products in China

Update from Advanced Cell on pre-clinical activities for its RPE cell program

Update from Advanced Cell on pre-clinical activities for its RPE cell program

Gamma Medica-Ideas closes $24 million financing to support digital technologies

Gamma Medica-Ideas closes $24 million financing to support digital technologies

Obesity can increase cancer incidence in leukemic children

Obesity can increase cancer incidence in leukemic children

GeoVax requests FDA meeting to discuss IND for its therapeutic HIV/AIDS vaccine

GeoVax requests FDA meeting to discuss IND for its therapeutic HIV/AIDS vaccine

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.